Predicting Thromboembolism and Selecting Patients for Anticoagulant Therapy in Atrial Fibrillation**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 8, 2008, Pages 816-817

  Weintraub, William S ^a  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD PRESSURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; EDITORIAL; FOOD DRUG INTERACTION; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; SINUS RHYTHM; STROKE; THROMBOEMBOLISM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; PATIENT SELECTION; PROGNOSIS; THROMBOEMBOLISM; WARFARIN;

EID: 39149115666     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.10.045     Document Type: Editorial

References (7)

1. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
2. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Circulation 114 (2006) e257-354.
3. Fang M.C., Go A.S., Chang Y., Borowsky L., Pomernacki N.K., Singer D.E., and ATRIA Study Group. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol 51 (2008) 810-815
4. Diamond G.A. What price perfection?. Calibration and discrimination of clinical prediction models. J Clin Epidemiol 45 (1992) 85-89
5. Lin H.J., Wolf P.A., Kelly-Hayes M., et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 27 (1996) 1760-1764
6. Wyse D.G., Waldo A.L., DiMarco J.P., et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
7. Madrid A.H., Bueno M.G., Rebollo J.M., et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 106 (2002) 331-336